Literature DB >> 2164935

The concept of selectivity in 5-HT receptor research.

I van Wijngaarden1, M T Tulp, W Soudijn.   

Abstract

Since the demonstration that serotonin (5-hydroxytryptamine, 5-HT) interacts with different (sub)types of membrane receptors, several compounds have been proposed as potent and selective ligands for one of these 5-HT subtypes. Unfortunately, specific and highly selective ligands (selectivity ratios greater than or equal to 1000) for the majority of 5-HT subtypes are still lacking. A few compounds are selective (ratios greater than or equal to 100), but most of the reputed 'selective' tools display affinities for other 5-HT subtypes and/or other (neuro-) transmitter receptors. Mainly due to different interpretations of the concept of selectivity, many of these nonselective compounds are still used to characterize 5-HT receptors. In this paper, we present the affinities (obtained by radioligand binding studies) of the most selective tools known today for each of the 5-HT subtypes and discuss the structure-activity relationships of some interesting series. The potential use of several of these selective ligands as pharmacological tools and therapeutics will be briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164935     DOI: 10.1016/0922-4106(90)90190-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  67 in total

1.  Spinal 5-HT-receptors and tonic modulation of transmission through a withdrawal reflex pathway in the decerebrated rabbit.

Authors:  R W Clarke; J Harris; A K Houghton
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy.

Authors:  Rahat Noor; Agop Y Bedikian; Sandy Mahoney; Roland Bassett; Kevin Kim; Nicholas Papadopoulos; Wen-Jen Hwu; Patrick Hwu; Jade Homsi
Journal:  Support Care Cancer       Date:  2012-01-25       Impact factor: 3.603

Review 3.  Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.

Authors:  Petra Feyer; M Heinrich Seegenschmiedt; Maria Steingraeber
Journal:  Support Care Cancer       Date:  2005-07-26       Impact factor: 3.603

Review 4.  Rationale for the use of 5-HT1-like agonists in the treatment of migraine.

Authors:  W Feniuk; P P Humphrey; M J Perren; H E Connor; E T Whalley
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 5.  Ondansetron: a review of its use as an antiemetic in children.

Authors:  C R Culy; N Bhana; G L Plosker
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Evidence for a 5-HT(1)-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery.

Authors:  I S de la Lande
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

7.  Effects of serotonergic agents on apomorphine-induced locomotor activity.

Authors:  K A Young; R Zavodny; P B Hicks
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?

Authors:  Tong J Gan
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.

Authors:  Kristin B Dupre; Corinne Y Ostock; Jessica A George; Karen L Eskow Jaunarajs; Cara M Hueston; Christopher Bishop
Journal:  ACS Chem Neurosci       Date:  2013-04-01       Impact factor: 4.418

10.  Opposing actions of 5HT1A and 5HT2-like serotonin receptors on modulations of the electric signal waveform in the electric fish Brachyhypopomus pinnicaudatus.

Authors:  Susan J Allee; Michael R Markham; Vielka L Salazar; Philip K Stoddard
Journal:  Horm Behav       Date:  2007-12-14       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.